EGFR and neoplasm: The RTK epidermal growth factor receptor (EGFR) activates AKT that directly phosphorylates β-catenin on Ser552, which increases the cytosolic and nuclear β-catenin levels and transcriptional regulation, thereby promoting tumor cell invasion (126).